In inflammation-associated CRC, IL-23R signaling in Treg cells inhibits carcinogenesis, whereas in sporadic CRC, IL-23R signaling in Treg cells promotes carcinogenesis. The gene discussed is IL23R; the disease is colorectal carcinoma.